Evidence map›Paper›PMID 33910964›Full record

ArticleJournal of clinical microbiology2021

Development and Evaluation of a Point-of-Care Test in a Low-Resource Setting with High Rates of Chlamydia trachomatis Urogenital Infections in Fiji.

Deborah Dean, Sumeetha Swaminathan, Mike Kama, Sophie Goemans, Daniel Faktaufon, Noor Alnabelseya, Dawn Spelke, Kamin Kahrizi, Matthew Black, Debkishore Mitra

Abstract read
In one paragraph

Article in Journal of clinical microbiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Deborah DeanDepartment of Medicine, University of California, San Francisco, California, USA.
Sumeetha SwaminathanDepartment of Pediatrics, University of California, San Francisco, California, USA.
Mike KamaFiji Centre for Communicable Disease Control, Ministry of Health and Medical Services, Suva, Fiji.
Sophie GoemansDepartment of Pediatrics, University of California, San Francisco, California, USA.
Daniel FaktaufonFiji Centre for Communicable Disease Control, Ministry of Health and Medical Services, Suva, Fiji.
Noor AlnabelseyaLucira Health, Emeryville, California, USA.
Dawn SpelkeLucira Health, Emeryville, California, USA.
Kamin KahriziLucira Health, Emeryville, California, USA.
Matthew BlackLucira Health, Emeryville, California, USA.
Debkishore MitraLucira Health, Emeryville, California, USA.

Funding

Low-Cost Instrument-free Point-of-care Platform for Multiplexed Chlamydia DiagnosticsR44AI114068 · NIAID · LUCIRA HEALTH, INC · PI DEAN, DEBORAH ANNE, MITRA, DEBKISHORE · 2016 to 2017
$1.4M
NIAID NIH HHS R44 AI114068
6 · The paper itself

Abstract

Rapid and precise detection of Chlamydia trachomatis, the leading global cause of sexually transmitted infections (STI), at the point of care (POC) is required for treatment decisions to prevent transmission and sequelae, including pelvic inflammatory disease, ectopic pregnancy, tubal factor infertility, and preterm birth. We developed a rapid POC test (POCT), termed LH-POCT, which uses

Indexed as

Chlamydia InfectionsGonorrheaPremature BirthAdolescentAdultChlamydia trachomatisFemaleFijiHumansInfant, NewbornNeisseria gonorrhoeaePoint-of-Care TestingPregnancyChlamydia trachomatislimit of detectionlow-resource settingpoint-of-care testsexually transmitted infections

Identifiers

PMID33910964
PMCPMC8218753

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.